Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$2.83 - $8.69 $50,940 - $156,420
-18,000 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$8.31 - $14.92 $1.51 Million - $2.72 Million
-182,000 Reduced 91.0%
18,000 $1,000
Q3 2021

Oct 28, 2021

BUY
$9.15 - $13.28 $1.83 Million - $2.66 Million
200,000 New
200,000 $10,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $8.15B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.